Agenus (AGEN) Goodwill & Intangibles (2010 - 2026)
Agenus (AGEN) posted quarterly Goodwill & Intangibles of $27.1 million for Q1 2026, down 1.21% year-over-year from $27.4 million in Q1 2025, and little changed quarter-over-quarter from $27.1 million in Q4 2025.
Analysis
Agenus (AGEN) Goodwill & Intangibles (2010 - 2026) Analysis & Trends
Agenus' Goodwill & Intangibles history runs 17 years deep, the most recent figure standing at $27.1 million for Q1 2026.
- In Q1 2026, Goodwill & Intangibles fell 1.21% year-over-year to $27.1 million; the TTM figure through Mar 2026 stood at $27.1 million (down 1.21% YoY), while the FY2025 annual figure was $27.1 million, down 38.98% from the prior year.
- Goodwill & Intangibles for Q1 2026 stood at $27.1 million, roughly flat from $27.1 million in the prior quarter.
- The five-year high for Goodwill & Intangibles was $48.0 million in Q1 2023, with the low at $27.1 million in Q1 2026.
- The 5-year median for Goodwill & Intangibles is $30.8 million (2022), against an average of $36.1 million.
- Peak annual rise in Goodwill & Intangibles reached 52.61% in 2024, while the deepest fall reached 39.71% in 2024.
- Agenus' Goodwill & Intangibles stood at $47.8 million in 2022, then slumped by 39.1% to $29.1 million in 2023, then surged by 52.61% to $44.5 million in 2024, then tumbled by 38.98% to $27.1 million in 2025, then decreased by 0.29% to $27.1 million in 2026.
- Business Quant data shows AGEN's Goodwill & Intangibles at $27.1 million in Q1 2026, $27.1 million in Q4 2025, and $44.5 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Agenus | 342.07 Mn | 342.07 Mn | 34.52 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 44.45 Mn |
| Mar 31, 2026 | 44.45 Mn |
| Dec 31, 2025 | 44.45 Mn |
| Sep 30, 2025 | 44.45 Mn |
| Jun 30, 2025 | 44.45 Mn |
| Mar 31, 2025 | 44.45 Mn |
| Dec 31, 2024 | 44.46 Mn |
| Sep 30, 2024 | 46.71 Mn |
| Jun 30, 2024 | 46.92 Mn |
| Mar 31, 2024 | 46.73 Mn |
| Dec 31, 2023 | 46.82 Mn |
| Sep 30, 2023 | 46.61 Mn |
| Jun 30, 2023 | 46.84 Mn |
| Mar 31, 2023 | 47.98 Mn |
| Dec 31, 2022 | 47.84 Mn |
| Sep 30, 2022 | 46.40 Mn |
| Jun 30, 2022 | 47.36 Mn |
| Mar 31, 2022 | 46.78 Mn |
| Dec 31, 2021 | 47.32 Mn |
| Sep 30, 2021 | 46.86 Mn |